The global medical nutrition market size was valued at USD 53.8 billion in 2025 and is projected to grow from USD 57.49 billion in 2026 to USD 97.83 billion by 2034 at a CAGR of 6.87% during the forecast period 2026-2034. North America dominated the medical nutrition market with a market share of 36.4% in 2025.
Download a Free Sample To learn more about this report,
The Medical Nutrition market trends are being driven by the increasing prevalence of chronic diseases, an aging global population, and greater awareness of nutrition as part of clinical treatment. Healthcare providers are increasingly prescribing disease-specific nutritional products for patients with diabetes, cancer, gastrointestinal disorders, kidney disease, and malnutrition. These specialized formulations help improve recovery, reduce hospital stays, and support long-term disease management. Hospitals and home healthcare providers are also expanding the use of oral nutritional supplements and enteral nutrition to improve patient outcomes.
Another important Medical Nutrition market trend is the development of personalized nutritional solutions tailored to individual health conditions, age, and recovery needs. Manufacturers are introducing high-protein, immune-supporting, and microbiome-focused formulations enriched with vitamins, minerals, omega-3 fatty acids, and probiotics. Digital health technologies are also being integrated to monitor nutritional status and improve treatment adherence.
The medical nutrition market is driven by the rising prevalence of chronic diseases, increasing aging populations, and growing awareness of disease-specific nutritional management. Medical nutrition products are increasingly prescribed for patients with cancer, diabetes, gastrointestinal disorders, and neurological conditions to improve recovery and treatment outcomes.
The medical nutrition market faces restraints due to the high cost of specialized nutritional formulations, strict regulatory requirements, and limited reimbursement coverage in several countries. Premium disease-specific nutrition products remain less affordable for many patients, particularly in low- and middle-income regions.
The medical nutrition market presents strong opportunities through the growing demand for personalized nutrition, expanding home healthcare services, and advances in disease-specific nutritional formulations. Increasing use of digital health platforms and remote patient monitoring is encouraging the integration of customized nutrition plans into chronic disease management.
The medical nutrition market faces challenges related to regulatory compliance, patient adherence, and maintaining product efficacy across diverse clinical conditions. Manufacturers must continuously invest in scientific research, clinical trials, and quality assurance while meeting evolving global regulatory standards.
Request Customizationto receive a tailored report.
Proteins Dominated the Market with 27.6% Share in 2025
The proteins segment accounted for the largest share of the global medical nutrition market at 27.6% in 2025, generating USD 14.85 billion in revenue. The segment's dominance is driven by the increasing use of high-protein nutritional formulations for muscle recovery, wound healing, disease management, and post-surgical care. Growing demand for protein-enriched medical nutrition among elderly patients and individuals with chronic illnesses further supports segment growth.
Geriatric Nutrition is Projected to Register the Fastest Growth at a CAGR of 7.6%
The geriatric nutrition segment is anticipated to witness the fastest growth, registering a CAGR of 7.6% during the forecast period. Increasing global aging populations, rising incidence of age-related diseases, and growing focus on healthy aging and nutritional support are driving demand for geriatric medical nutrition products.
Oral Nutrition Dominated the Market with 55.3% Share in 2025
The oral nutrition segment accounted for the largest share of the medical nutrition market at 55.3% in 2025, generating USD 29.75 billion in revenue. The segment's leadership is attributed to the convenience of oral nutritional supplements, high patient compliance, and widespread use in hospitals, outpatient care, and home healthcare settings.
Malnutrition is Projected to Register the Fastest Growth at a CAGR of 8.1%
The malnutrition segment is projected to witness the fastest growth, registering a CAGR of 8.1% during the forecast period. Rising awareness of disease-related malnutrition, increasing hospital screening programs, and expanding clinical nutrition initiatives are supporting rapid growth in this segment.
Hospitals Dominated the Market with 41.6% Share in 2025
The hospitals segment accounted for the largest share of the global medical nutrition market at 41.6% in 2025, generating USD 22.38 billion in revenue. The segment's dominance is attributed to the high volume of inpatient care, increasing use of enteral and parenteral nutrition, and the availability of specialized clinical nutrition programs in hospitals.
Speak to an Analystto discuss market opportunities.
North America accounted for 36.4% of the global medical nutrition market, valued at USD 19.58 billion in 2025. The region benefits from advanced healthcare infrastructure, high adoption of clinical nutrition therapies, growing prevalence of chronic diseases, and increasing demand for disease-specific nutritional products. Strong reimbursement frameworks and expanding home healthcare services continue to support market growth across the region.
The United States accounted for an estimated USD 16.84 billion in 2025, making it the largest contributor in North America. Growth is driven by increasing cases of cancer, diabetes, and gastrointestinal disorders, rising demand for enteral and oral nutritional supplements, and strong investments in clinical nutrition across hospitals and homecare settings.
Canada generated an estimated USD 2.74 billion in 2025. Rising healthcare expenditure, growing aging population, increasing awareness of disease-related malnutrition, and expanding adoption of medical nutrition products in hospitals and long-term care facilities are driving market growth across the country.
Europe accounted for 28.1% of the global medical nutrition market, reaching USD 15.12 billion in 2025. The market is supported by well-established public healthcare systems, increasing elderly populations, growing demand for specialized nutritional therapies, and rising adoption of clinical nutrition guidelines for chronic disease management and recovery.
The United Kingdom represented an estimated USD 2.87 billion in 2025. The country's market is driven by increasing demand for disease-specific nutritional support, expanding home healthcare services, and NHS initiatives promoting nutritional care for patients with chronic illnesses and age-related conditions.
Germany accounted for an estimated USD 3.84 billion in 2025, making it one of Europe's leading medical nutrition markets. Strong healthcare infrastructure, increasing hospital-based nutrition programs, and growing demand for enteral and parenteral nutrition continue to support market expansion.
Asia Pacific accounted for 24.7% of the global medical nutrition market, valued at USD 13.29 billion in 2025, and is projected to register the fastest regional CAGR of 8.3% during the forecast period. Rising healthcare expenditure, expanding hospital infrastructure, increasing prevalence of chronic diseases, and growing awareness of clinical nutrition are accelerating market growth across the region.
Japan generated an estimated USD 2.79 billion in 2025. The country's rapidly aging population, increasing demand for geriatric nutrition, and widespread adoption of specialized nutritional therapies continue to fuel demand for medical nutrition products.
China accounted for an estimated USD 5.58 billion in 2025, making it the largest market in Asia Pacific. Rising healthcare investments, increasing incidence of chronic diseases, expanding hospital infrastructure, and growing consumer awareness of preventive and therapeutic nutrition are driving strong market growth.
The Middle East & Africa represented 4.6% of the global medical nutrition market, totaling USD 2.47 billion in 2025. Increasing investments in healthcare infrastructure, rising prevalence of lifestyle-related diseases, expanding access to clinical nutrition products, and growing awareness of disease-related malnutrition are supporting regional market growth.
The United Arab Emirates (UAE) accounted for an estimated USD 0.62 billion in 2025. The market is driven by growing investments in healthcare modernization, increasing demand for specialized nutritional products, expanding private healthcare services, and rising awareness of preventive nutrition.
Africa is witnessing steady growth in the medical nutrition market, supported by improving healthcare access, increasing government initiatives to combat malnutrition, and expanding availability of clinical nutrition products. In 2025, the regional market was estimated at USD 1.85 billion. Rising investments in hospital nutrition programs, maternal and child health initiatives, and chronic disease management are expected to create long-term growth opportunities for medical nutrition manufacturers across the continent.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Associate
Mitiksha Koul is a Research Associate with 2 years of experience in market research. She focuses on analyzing industry trends, competitive landscapes, and growth opportunities to support strategic decision-making. Mitiksha’s strong analytical skills and research expertise enable her to deliver actionable insights that help businesses adapt to evolving market dynamics and achieve sustainable growth.
We are featured on:
sales@straitsresearch.com